الرئيسيةعريقبحث

نيتازوكسانيد

مركب كيميائي

نيتازوكسانيد (Nitazoxanide)‏ هو دواء يُستعمل في علاج:[4][5][6]

نيتازوكسانيد
يعالج
اعتبارات علاجية
معرّفات
CAS 55981-09-4 
ك ع ت P01AX11 
بوب كيم 41684 
ECHA InfoCard ID 100.054.465 
درغ بنك 00507 
كيم سبايدر 38037 
المكون الفريد SOA12P041N 
كيوتو D02486 
ChEMBL CHEMBL1401 
بيانات كيميائية
الصيغة الكيميائية C₁₂H₉N₃O₅S[3] 

دوره

يلعب هذا الدواء دورًا في علاج الأمراض كونه:[8]

المراجع

  1. معرف المصطلحات المرجعية بملف المخدرات الوطني: https://bioportal.bioontology.org/ontologies/NDFRT?p=classes&conceptid=N0000148784 — تاريخ الاطلاع: 13 ديسمبر 2016
  2. معرف المصطلحات المرجعية بملف المخدرات الوطني: https://bioportal.bioontology.org/ontologies/NDFRT?p=classes&conceptid=N0000148784 — المؤلف: Lyne Jossé و Anastasios D Tsaousis — العنوان : Past and future trends of Cryptosporidium in vitro research — المجلد: 196 — الصفحة: 28-37 — نشر في: Experimental Parasitology — https://dx.doi.org/10.1016/J.EXPPARA.2018.12.001https://pubmed.ncbi.nlm.nih.gov/30521793https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333944 — الرخصة: Creative Commons Attribution 4.0 International
  3. معرف بوب كيم: https://pubchem.ncbi.nlm.nih.gov/compound/41684 — تاريخ الاطلاع: 19 نوفمبر 2016 — العنوان : NITAZOXANIDE — الرخصة: محتوى حر
  4. Rossignol JF (October 2014). "Nitazoxanide: a first-in-class broad-spectrum antiviral agent". Antiviral Res. 110: 94–103. doi:10.1016/j.antiviral.2014.07.014. PMID 25108173. Originally developed and commercialized as an antiprotozoal agent, nitazoxanide was later identified as a first-in-class broad-spectrum antiviral drug and has been repurposed for the treatment of influenza. ... From a chemical perspective, nitazoxanide is the scaffold for a new class of drugs called thiazolides. These small-molecule drugs target host-regulated processes involved in viral replication. ... A new dosage formulation of nitazoxanide is presently undergoing global Phase 3 clinical development for the treatment of influenza. Nitazoxanide inhibits a broad range of influenza A and B viruses including influenza A(pH1N1) and the avian A(H7N9) as well as viruses that are resistant to neuraminidase inhibitors. ... Nitazoxanide also inhibits the replication of a broad range of other RNA and DNA viruses including respiratory syncytial virus, parainfluenza, coronavirus, rotavirus, norovirus, hepatitis B, hepatitis C, dengue, yellow fever, Japanese encephalitis virus and human immunodeficiency virus in cell culture assays. Clinical trials have indicated a potential role for thiazolides in treating rotavirus and norovirus gastroenteritis and chronic hepatitis B and chronic hepatitis C. Ongoing and future clinical development is focused on viral respiratory infections, viral gastroenteritis and emerging infections such as dengue fever.
  5. Di Santo N, Ehrisman J (2013). "Research perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose?". Cancers (Basel). 5 (3): 1163–1176. doi:10.3390/cancers5031163. PMC . PMID 24202339. Nitazoxanide [NTZ: 2-acetyloxy-N-(5-nitro-2-thiazolyl)benzamide] is a thiazolide antiparasitic agent with excellent activity against a wide variety of protozoa and helminths.  ... Nitazoxanide (NTZ) is a main compound of a class of broad-spectrum anti-parasitic compounds named thiazolides. It is composed of a nitrothiazole-ring and a salicylic acid moiety which are linked together by an amide bond ... NTZ is generally well tolerated, and no significant adverse events have been noted in human trials [13]. ... In vitro, NTZ and tizoxanide function against a wide range of organisms, including the protozoal species Blastocystis hominis, C. parvum, Entamoeba histolytica, G. lamblia and Trichomonas vaginalis [13]
  6. White CA (2004). "Nitazoxanide: a new broad spectrum antiparasitic agent". Expert Rev Anti Infect Ther. 2 (1): 43–9. doi:10.1586/14787210.2.1.43. PMID 15482170.
  7. "معرف المصطلحات المرجعية بملف المخدرات الوطني". المصطلحات المرجعية بملف العقاقير الوطني. مؤرشف من الأصل في 30 مايو 201913 ديسمبر 2016.
  8. "معرف المصطلحات المرجعية بملف المخدرات الوطني". المصطلحات المرجعية بملف العقاقير الوطني. مؤرشف من الأصل في 30 مايو 20195 مارس 2018.

موسوعات ذات صلة :